Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
14.22
+0.30 (2.16%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Kazia Therapeutics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 0.89 | 0.04 | 2.31 | 0 | 0.03 | 15.18 | |
Revenue Growth (YoY) | -93.67% | -98.19% | 230745.00% | -96.00% | -99.83% | 1425.93% |
Cost of Revenue | 4.03 | - | - | - | - | - |
Gross Profit | -3.14 | 0.04 | 2.31 | 0 | 0.03 | 15.18 |
Selling, General & Admin | 10.72 | 8.72 | 13.56 | 8.58 | 5.24 | 7.02 |
Depreciation & Amortization Expenses | 0.83 | - | - | - | - | - |
Research & Development | 4.08 | 7.33 | 17.38 | 15.56 | 20.17 | 14.54 |
Other Operating Expenses | - | 13.38 | - | - | - | - |
Total Operating Expenses | 15.62 | 29.43 | 30.94 | 24.15 | 25.41 | 21.56 |
Operating Income | -18.76 | -29.38 | -28.64 | -24.15 | -25.38 | -6.38 |
Interest Income | 0.66 | 0.07 | 0.01 | 0.02 | 0 | 0.04 |
Interest Expense | -0.14 | - | - | - | - | - |
Other Non-Operating Income (Expense) | - | 5.08 | 1.4 | 3.39 | - | -2.57 |
Total Non-Operating Income (Expense) | 0.52 | 5.15 | 1.41 | 3.41 | 0 | -2.53 |
Pretax Income | -4.23 | -22.45 | -27.05 | -20.74 | -25.38 | -8.9 |
Provision for Income Taxes | - | -1.75 | -0.27 | -0.27 | -0.37 | -0.48 |
Net Income | -4.23 | -20.7 | -26.78 | -20.47 | -25.01 | -8.42 |
Net Income to Common | -8.24 | -20.7 | -26.78 | -20.47 | -25.01 | -8.42 |
Shares Outstanding (Basic) | 0 | 1 | 1 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 0 | 1 | 1 | 0 | 0 | 0 |
Shares Change (YoY) | -78.90% | 107.81% | 43.08% | 39.12% | 12.57% | 61.08% |
EPS (Basic) | -32.23 | -18.90 | -50.80 | -56.15 | -94.40 | -35.80 |
EPS (Diluted) | -32.23 | -18.90 | -50.80 | -56.15 | -94.40 | -35.80 |
Free Cash Flow | -19.16 | -13.35 | -9.58 | -15.16 | -22.76 | -9.11 |
Free Cash Flow Per Share | -100.41 | -12.18 | -18.17 | -41.12 | -85.92 | -38.71 |
Gross Margin | -354.63% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -2118.20% | -70355.90% | -1240.50% | -2414600.00% | -101536.00% | -42.01% |
Profit Margin | -477.33% | -49567.60% | -1160.00% | -2046500.00% | -100056.00% | -55.46% |
FCF Margin | -2163.25% | -31968.80% | -415.04% | -1515600.00% | -91048.00% | -60.01% |
EBITDA | -18.76 | -28.45 | -26.77 | -22.28 | -23.52 | -5.11 |
EBITDA Margin | -2118.20% | -68117.90% | -1159.53% | -2227700.00% | -94060.00% | -33.68% |
EBIT | -18.76 | -29.38 | -28.64 | -24.15 | -25.38 | -6.38 |
EBIT Margin | -2118.20% | -70355.90% | -1240.50% | -2414600.00% | -101536.00% | -42.01% |
Effective Tax Rate | - | 7.78% | 1.00% | 1.31% | 1.45% | 5.44% |